 DNA flow cytometry colorectal carcinoma correlation DNA stemlines prognostic indices DNA flow cytometry FCM paraffin-embedded tissue blocks colorectal carcinomas CRC Forty-seven percent tumors aneuploidy diploid Seventy-two percent patients aneuploid diploid group alive mean follow-up months survival site tumor location Dukes stage serum CEA level certain DNA stemline irrespective ploidy pattern serum CEA level mortality poor survival Dukes stage mortality Forty-six percent patients lesions Dukes advanced stage adjuvant therapy Eighty-five percent subgroup patients patients aneuploid tumors role FCM assessment prognosis CRC clinical evaluation randomized control trial